TARGOVAX SOLUTIONS AS
Operating
Salg og utvikling av biomedisinske produkter og tjenester. Formålet
kan fremmes ved deltakelse i eller samarbeid med andre foretak i inn-
og utland.
Forskning og utviklingsarbeid innen bioteknologi.
Organization
- CEO
- ED
- Chairman of the board
- ED
- Years since formation
- 5 years
- since May 26, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 7,337,000
- NOK
- Annual total result 2025
- -5,724,000
- NOK
- Total equity 2025
- -801,424,000
- NOK
Last update: Oct 31, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ED | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
ED | Chairman | - |
LH 1971 | Board Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MT 1954 | - | 2.99 % indirectly |
KO 1954 | - | 2.47 % indirectly |
VA | - | 2.09 % indirectly |
EH 1959 | - | 1.97 % indirectly |
OA | - | 1.89 % indirectly |
TA 1967 | - | 1.74 % indirectly |
AS | - | 1.69 % indirectly |
EP 1977 | - | 1.61 % indirectly |
UE | - | 1.59 % indirectly |
AF | - | 1.14 % indirectly |
Last update: Oct 31, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,000 | 100 % |
Last update: Sep 25, 2026
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -9,520,000Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 7,337,000 | 7,641,000 | 8,385,000 | 26,579,000 | 0 |
Annual Total Result | -5,724,000 | -9,305,000 | -50,179,000 | -740,786,000 | 0 |
Total assets | 98,006,000 | 68,945,000 | 24,217,000 | 63,957,000 | 39,930 |
Total liabilities | 899,431,000 | 865,417,000 | 811,916,000 | 801,928,000 | 0 |
Total equity | -801,424,000 | -796,471,000 | -787,700,000 | -737,971,000 | 39,930 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 7,337,000 | 7,641,000 | 8,385,000 | 26,579,000 | 0 |
Total operating costs | 12,952,000 | 15,373,000 | 29,910,000 | 72,816,000 | 0 |
Operating result | -5,615,000 | -7,732,000 | -21,525,000 | -46,237,000 | 0 |
Financial income/costs | -109,000 | -1,573,000 | -28,654,000 | -694,549,000 | 0 |
Profit before tax | -5,724,000 | -9,305,000 | -50,179,000 | -740,786,000 | 0 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -5,724,000 | -9,305,000 | -50,179,000 | -740,786,000 | 0 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 93,481,000 | 55,789,000 | 17,385,000 | 1,075,000 | 0 |
Total current assets | 4,525,000 | 13,156,000 | 6,832,000 | 62,882,000 | 39,930 |
Total assets | 98,006,000 | 68,945,000 | 24,217,000 | 63,957,000 | 39,930 |
Short term debt | 899,431,000 | 865,417,000 | 811,916,000 | 801,928,000 | 0 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 899,431,000 | 865,417,000 | 811,916,000 | 801,928,000 | 0 |
Contributed capital | 30,000 | 30,000 | 40,000 | 40,000 | 39,930 |
Retained earnings | -801,454,000 | -796,501,000 | -787,740,000 | -738,011,000 | 0 |
Total equity | -801,424,000 | -796,471,000 | -787,700,000 | -737,971,000 | 39,930 |
Total equity and liabilities | 98,007,000 | 68,946,000 | 24,216,000 | 63,957,000 | 39,930 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification